Overview

Efficacy of Oral Colchicine in Prevention of Proliferative Vitreoretinopathy in Rhegmatogenous Retinal Detachment

Status:
Unknown status
Trial end date:
2006-08-01
Target enrollment:
0
Participant gender:
All
Summary
This clinical trial will test the efficacy and safety of oral colchicine in prevention of proliferative vitreoretinopathy (PVR) in cases of rhegmatogenous retinal detachment
Phase:
Phase 3
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Shahid Beheshti University of Medical Sciences
Treatments:
Colchicine
Criteria
Inclusion Criteria:

- Rhegmatogenous retinal detachment

Exclusion Criteria:

- PVR grade C

- Duration of retinal detachment ≥ one month

- History of cataract surgery

- History of RD surgery